Therapeutic efficacy of 177Lu-labeled A20FMDV2 peptides targeting ανβ6

Authors

Truc Thao Huynh, Washington University School of Medicine in St. Louis
Sreeja Sreekumar, Washington University School of Medicine in St. Louis
Cedric Mpoy, Washington University School of Medicine in St. Louis
Buck Edward Rogers, Washington University School of Medicine in St. Louis

Journal

Pharmaceuticals

Publication Date

2-15-2022

Volume

15

Issue

2

First Page

229

Document Type

Open Access Publication

DOI

10.3390/ph15020229

Rights and Permissions

Huynh TT, Sreekumar S, Mpoy C, Rogers BE. Therapeutic Efficacy of 177Lu-Labeled A20FMDV2 Peptides Targeting ανβ6. Pharmaceuticals (Basel). 2022 Feb 15;15(2):229. doi: 10.3390/ph15020229. Copyright: © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Recommended Citation

Huynh, Truc Thao; Sreekumar, Sreeja; Mpoy, Cedric; and Rogers, Buck Edward, "Therapeutic efficacy of 177Lu-labeled A20FMDV2 peptides targeting ανβ6." Pharmaceuticals. 15, 2. 229 (2022).
https://digitalcommons.wustl.edu/oa_4/3472

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.